Question normal

DDM is a non-prescription, non-invasive, drug free tool designed for diabetes wellness. It converges digital therapeutics and digital connect with real time patient generated data to activate body's own immunity by repairing impaired cells and facilitating nutrient absorption. It is a safe, portable and cost effective device for home use. It will reduce dependence on modern medicine, their side effects, complications, and can be a significant help for predicting and preventing diabetes worldwide.

Our mission is to deploy modern technology to regulate, high blood sugar by slowly replacing the patient’s medicinal intake with life style based integrated care that prevents long term side effects.

According to United Health, by 2020 every other person in U.S. will be diabetic or pre-diabetic, and the United States will spend $3.4 trillion in the next decade on diabetic-related care. Devices have accounted for about $78 billion a year market opportunity. DDM is a revolutionizing technique that will train and reactivate cells at the quantum level, and promote natural processes.

Our research has documented that metabolic disorders result from imbalances, contaminants, and toxins that regulate immune response. Pancreatic therapy will repair and regenerate islets of langerhans cells which facilitate hormones that enhance their ability to produce insulin, regulate, and treat high blood sugar. Diabetic patient's frustration with prescription drugs has strengthened their belief in therapeutic treatment especially after the recent FDA’s red-flagging of Actos, Avandia, and Byetta for several deaths. Modern medicine is just like fixing a leak at one place, while there are a leaks elsewhere. This frustration, coupled with the high cost of pharmaceuticals and their long term dangerous side effects, provides a timely market opportunity for DDM.

More than 554 million people suffer from diabetes worldwide, and same number of population don't even know if they have this disorder. About 97 million Americans are obese and one third of children are destined to be diabetic. According to recent CDC reports, 79 million American adults have pre-diabetes, by 2020, one in two Americans could have diabetes or pre-diabetes and 75% of Americans could be overweight or obese. 80% of the healthcare dollars are consumed by 20% of the population. The total annual cost of diabetes in 2010 was estimated at $195 billion, and $140 billion for obesity. An average diabetic patient shopping in a family pharmacy is spending about $3,200 a year, which is 10% more than a non-diabetic patient .